TrialAdvances in therapy2026

Long-Acting Cabotegravir Injections Are More Acceptable Than Long-Acting Lenacapavir Injections After One Dose: Results From the CLARITY Randomized Crossover Study.

Emilie R Elliot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.